rs1426488816
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs387907272
|
|
|
0.060 |
GeneticVariation |
BEFREE |
To sum up, ASO-RQ-PCR is an inexpensive, robust, and optimized method for the detection of MYD88 L265P mutation, which could be considered as a useful molecular tool during the diagnostic work-up of B-cell lymphoproliferative disorders.
|
24992174 |
2015 |
rs387907272
|
|
|
0.060 |
GeneticVariation |
BEFREE |
An oncogenic gain-of-function mutation (L265P) in the human MYD88 gene has been found to be present in most cases of WM/LPL, yet is absent in most other cases of B-cell chronic lymphoproliferative disorders (LPD), including SMZL.
|
24842316 |
2014 |
rs387907272
|
|
|
0.060 |
GeneticVariation |
BEFREE |
The absence of plasmacytoid cells, the presence of plasma cells predominantly outside the nodular lymphoid infiltrates, IGHV4-34 restriction and absence of MYD88 L265P mutation strongly suggest that cold agglutinin-associated lymphoproliferative disease is a distinct entity that is different from lymphoplasmacytic lymphoma.
|
24143001 |
2014 |
rs387907272
|
|
|
0.060 |
GeneticVariation |
BEFREE |
This has fueled major interest in the field and as newer evidence accumulates, it is clear that that discovery of MYD88 L265P mutation may represent an important breakthrough in understanding the pathogenesis of WM and lymphoproliferative disorders.
|
24573383 |
2014 |
rs387907272
|
|
|
0.060 |
GeneticVariation |
BEFREE |
MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders.
|
23955458 |
2013 |
rs387907272
|
|
|
0.060 |
GeneticVariation |
BEFREE |
We evaluated the MYD88 L265P mutation in Waldenström's macroglobulinemia (WM) and B-cell lymphoproliferative disorders by specific polymerase chain reaction (PCR) (sensitivity ∼10(-3)).
|
23446312 |
2013 |
rs113488022
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Hairy cell leukemia (HCL) is an uncommon B-cell chronic lymphoproliferative disorder whose pathogenesis and recurrence are strictly dependent on the presence of the BRAF V600E mutant.
|
31354304 |
2019 |
rs121913377
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Hairy cell leukemia (HCL) is an uncommon B-cell chronic lymphoproliferative disorder whose pathogenesis and recurrence are strictly dependent on the presence of the BRAF V600E mutant.
|
31354304 |
2019 |
rs113488022
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders.
|
23161722 |
2012 |
rs121913377
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders.
|
23161722 |
2012 |
rs77375493
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In this patient and in 2 relatives with lymphoproliferative disorders, we searched for JAK2(V617F) mutation in lymphocytes.
|
19816006 |
2009 |
rs77375493
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The JAK2(V617F) mutation, which has been found in patients with myeloproliferative disorders (MPD), has not yet been evaluated in lymphoproliferative disorders by any adequately sensitive techniques.
|
18032883 |
2007 |
rs1217691063
|
|
|
0.020 |
GeneticVariation |
BEFREE |
As a conclusion, MTHFR C677T polymorphism does not increase the risk of lymphoproliferative disease, and it does not have an effect on chemotherapy response significantly; however, the patients with TT genotype have a slightly increased risk for ALL, and they also respond worse than CC genotype.
|
16944145 |
2006 |
rs1217691063
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We analysed the genotype frequencies of C677T-MTHFR in a group of 143 patients with lymphoproliferative disorders (REAL classification) and 200 controls.
|
11342344 |
2000 |
rs2071286
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We analyzed NOTCH4 rs2071286 and HLA-II rs9461776 in 3 HCV-related LPD groups (asymptomatic MC, MCS, NHL) with HCV infection without lymphoproliferative disorders.
|
29069725 |
2017 |
rs9461776
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We analyzed NOTCH4 rs2071286 and HLA-II rs9461776 in 3 HCV-related LPD groups (asymptomatic MC, MCS, NHL) with HCV infection without lymphoproliferative disorders.
|
29069725 |
2017 |
rs104893626
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We screened 418 patients with B-cell lymphoproliferative disorders and described the presence of the C1013G/CXCR4 warts, hypogammaglobulinemia, infections, and myelokathexis-associated mutation in 28.2% (37/131) of patients with lymphoplasmacytic lymphoma (Waldenström macroglobulinemia [WM]), being either absent or present in only 7% of other B-cell lymphomas.
|
24711662 |
2014 |
rs1472503583
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The absence of plasmacytoid cells, the presence of plasma cells predominantly outside the nodular lymphoid infiltrates, IGHV4-34 restriction and absence of MYD88 L265P mutation strongly suggest that cold agglutinin-associated lymphoproliferative disease is a distinct entity that is different from lymphoplasmacytic lymphoma.
|
24143001 |
2014 |
rs757085537
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The absence of plasmacytoid cells, the presence of plasma cells predominantly outside the nodular lymphoid infiltrates, IGHV4-34 restriction and absence of MYD88 L265P mutation strongly suggest that cold agglutinin-associated lymphoproliferative disease is a distinct entity that is different from lymphoplasmacytic lymphoma.
|
24143001 |
2014 |
rs773862672
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We screened 418 patients with B-cell lymphoproliferative disorders and described the presence of the C1013G/CXCR4 warts, hypogammaglobulinemia, infections, and myelokathexis-associated mutation in 28.2% (37/131) of patients with lymphoplasmacytic lymphoma (Waldenström macroglobulinemia [WM]), being either absent or present in only 7% of other B-cell lymphomas.
|
24711662 |
2014 |
rs75002266
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Here, we describe 3 patients with B-cell lymphoproliferative disorders (2 with non-Hodgkin lymphoma and 1 with nonsecretory multiple myeloma) carrying a novel A286V mutation within ORC4L gene.
|
20010161 |
2009 |
rs201478192
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The JAK2(V617F) mutation, which has been found in patients with myeloproliferative disorders (MPD), has not yet been evaluated in lymphoproliferative disorders by any adequately sensitive techniques.
|
18032883 |
2007 |